rituximab vs. tocilizimab for scleroderma: which is better?
Published 4 months ago • 314 plays • Length 4:19Download video MP4
Download video MP3
Similar videos
-
5:04
tocilizumab preserves lung function in systemic sclerosis
-
0:54
what is systemic sclerosis or scleroderma?
-
7:55
rituximab to treat systemic features of sjogren's
-
1:00
anti-scl 70 antibodies: their role in diagnosing scleroderma
-
4:23
rheumatological diseases: scleroderma (systemic sclerosis)
-
5:34
limited scleroderma (crest) vs diffuse scleroderma | rheumatology
-
35:27
juvenile onset systemic scleroderma: what is it and how is it evaluated and treated
-
4:43
safety and efficacy of subcutaneous tocilizumab in systemic sclerosis
-
5:08
hear from a treasure valley woman battling scleroderma
-
3:51
a tour of the various drug therapies for scleroderma
-
2:51
clinically staging and defining scleroderma | upmc
-
4:53
signs and symptoms of scleroderma | johns hopkins
-
3:25
scleroderma, what is it?
-
32:06
rituximab (rituxan/truxima) for multiple sclerosis explained by neurologist
-
2:35
scleroderma stories - rute
-
5:26
scleroderma vs systemic sclerosis
-
10:39
systemic sclerosis and scleroderma: visual explanation for students
-
2:45
what is the relationship between scleroderma and ph
-
42:38
current advancements in scleroderma treatment